Acquisitions - Schedule of Intangible Assets Acquisition (Details) - Jamestown Regional Medical Center [Member] - USD ($) |
12 Months Ended | |
|---|---|---|
Dec. 31, 2018 |
Dec. 31, 2019 |
|
| Certificate of Need [Member] | ||
| Intangible assets acquired | $ 259,443 | |
| Intangible assets, life description | Infinite | |
| Intangible assets, impairment | ||
| Intangible assets, amortization | ||
| Intangible assets, carrying Value | 259,443 | $ 259,443 |
| Non-compete [Member] | ||
| Intangible assets acquired | $ 245,363 | |
| Intangible assets, life | 2 years | |
| Intangible assets, impairment | $ (173,799) | |
| Intangible assets, amortization | (71,564) | |
| Intangible assets, carrying Value | ||
| Total Intangibles [Member] | ||
| Intangible assets acquired | 504,806 | |
| Intangible assets, impairment | (173,799) | |
| Intangible assets, amortization | (71,564) | |
| Intangible assets, carrying Value | $ 259,443 | $ 259,443 |
| X | ||||||||||
- Definition Intangible assets, life description. No definition available.
|
| X | ||||||||||
- Definition The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. No definition available.
|
| X | ||||||||||
- Definition Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|